DB05675ExperimentalProtein Based Therapies
EP-2104R is an imaging pharmaceutical under development for the detection of blood clots. It is the first targeted high-resolution technique designed to visualize blood clots directly. It is being developed...
- Mechanism
- Curator reviewed
EP-2104R binds specifically to fibrin, a protein present in all blood clots. When bound, it can be detected using a magnetic resonance imaging (MRI) scan.
- Primary indication
- Investigated for use/treatment in cardiovascular disorders and thrombosis.Curator reviewed
- Code names
- EP-2104R
Resolves to
Targets
What you can answer from here — as of March 06, 2025
1Protein targetEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with EP-2104R, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account